OTCPK:TGVN

Stock Analysis Report

TGC Ventures International

Executive Summary

TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Share Price & News

How has TGC Ventures International's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

TGVN

0.6%

US Healthcare

1.0%

US Market


1 Year Return

900.0%

TGVN

-9.4%

US Healthcare

6.7%

US Market


Share holder returns

TGVNIndustryMarket
7 Day0%0.6%1.0%
30 Day0%-3.3%-1.8%
90 Dayn/a-8.9%-1.8%
1 Year900.0%900.0%-8.0%-9.4%9.1%6.7%
3 Year-100.0%-100.0%30.0%24.8%46.1%36.6%
5 Yearn/a60.1%50.5%66.9%48.6%

Price Volatility Vs. Market

How volatile is TGC Ventures International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is TGC Ventures International undervalued based on future cash flows and its price relative to the stock market?


Intrinsic Value Based on Future Cash Flows

Undervalued: Insufficient data to calculate TGVN's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate TGVN's fair value to establish if it is undervalued.


Price Based on Earnings

PE vs Industry: Insufficient data to calculate TGVN's PE Ratio to determine if it is good value compared to the Healthcare industry average.

PE vs Market: Insufficient data to calculate TGVN's PE Ratio to determine if it is good value compared to the US market.


Price Based on Expected Growth

Low PEG Ratio: Insufficient data to calculate TGVN's PEG Ratio to determine if it is good value.


Price Based on Value of Assets

PB vs Industry: Insufficient data to calculate TGVN's PB Ratio to determine if it is good value.


Next Steps

Future Growth

How is TGC Ventures International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Earnings vs Savings Rate: Insufficient data to determine if TGVN's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if TGVN's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TGVN's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if TGVN's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Estimates


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has TGC Ventures International performed over the past 5 years?

13.9%

Historical Healthcare annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if TGVN's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare TGVN's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if TGVN's earnings growth over the past year exceeded the Healthcare industry average.


Return on Equity

High ROE: TGVN has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: Insufficient data to calculate TGVN's Return on Assets to determine if it is higher than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: Insufficient data to calculate TGVN's Return on Capital Employed to determine if it has improved over the past 3 years.


Next Steps

Financial Health

How is TGC Ventures International's financial position?


Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if TGVN's short term assets cover its short term liabilities

Long Term Liabilities: TGVN has no long term liabilities


Debt to Equity History and Analysis

Debt Level: TGVN is debt free.

Reducing Debt: TGVN has not had any debt for past 5 years.


Balance Sheet

Information is not available.

Information is not available.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if TGVN has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TGVN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is TGC Ventures International's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.3%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Notable Dividend: Unable to evaluate TGVN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate TGVN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if TGVN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TGVN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TGVN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of TGC Ventures International's salary, the management and board of directors tenure and is there insider trading?


CEO

TGC Ventures International has no CEO, or we have no data on them.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Management Team

  • Michael Woo

    President

    • Tenure: 0yrs

Board Members

  • George Grant

    Director

    • Tenure: 13.1yrs
  • Stanley Chiang

    Chairman

    • Tenure: 0yrs

Company Information

TGC Ventures International, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: TGC Ventures International, Inc.
  • Ticker: TGVN
  • Exchange: OTCPK
  • Founded: 2003
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$12.000
  • Shares outstanding: 1.20m
  • Website: https://null

Location

  • TGC Ventures International, Inc.
  • 1170 Peachtree Street NE
  • Atlanta
  • Georgia
  • 30309
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TGVNOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2004

Biography

TGC Ventures International, Inc. operates early detection cancer clinics, using infra-red thermal imaging technology. The technology is used as diagnosis to determine structure changes in tissues to detect ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/12 23:59
End of Day Share Price2019/05/15 00:00
Earnings2006/07/31
Annual Earnings2006/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)